212 related articles for article (PubMed ID: 29949049)
1. Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation.
Kraus D; Reckenbeil J; Veit N; Kuerpig S; Meisenheimer M; Beier I; Stark H; Winter J; Probstmeier R
Cell Oncol (Dordr); 2018 Oct; 41(5):485-494. PubMed ID: 29949049
[TBL] [Abstract][Full Text] [Related]
2. Targeting of Glucose Transport and the NAD Pathway in Neuroendocrine Tumor (NET) Cells Reveals New Treatment Options.
Winter J; Kunze R; Veit N; Kuerpig S; Meisenheimer M; Kraus D; Glassmann A; Probstmeier R
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900207
[TBL] [Abstract][Full Text] [Related]
3. Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer.
Espindola-Netto JM; Chini CCS; Tarragó M; Wang E; Dutta S; Pal K; Mukhopadhyay D; Sola-Penna M; Chini EN
Oncotarget; 2017 Oct; 8(49):85054-85067. PubMed ID: 29156703
[TBL] [Abstract][Full Text] [Related]
4. A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death.
Wood TE; Dalili S; Simpson CD; Hurren R; Mao X; Saiz FS; Gronda M; Eberhard Y; Minden MD; Bilan PJ; Klip A; Batey RA; Schimmer AD
Mol Cancer Ther; 2008 Nov; 7(11):3546-55. PubMed ID: 19001437
[TBL] [Abstract][Full Text] [Related]
5. Fasentin diminishes endothelial cell proliferation, differentiation and invasion in a glucose metabolism-independent manner.
Ocaña MC; Martínez-Poveda B; Marí-Beffa M; Quesada AR; Medina MÁ
Sci Rep; 2020 Apr; 10(1):6132. PubMed ID: 32273578
[TBL] [Abstract][Full Text] [Related]
6. Anti-proliferation effect of APO866 on C6 glioblastoma cells by inhibiting nicotinamide phosphoribosyltransferase.
Zhang LY; Liu LY; Qie LL; Ling KN; Xu LH; Wang F; Fang SH; Lu YB; Hu H; Wei EQ; Zhang WP
Eur J Pharmacol; 2012 Jan; 674(2-3):163-70. PubMed ID: 22119381
[TBL] [Abstract][Full Text] [Related]
7. The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors.
Watson M; Roulston A; Bélec L; Billot X; Marcellus R; Bédard D; Bernier C; Branchaud S; Chan H; Dairi K; Gilbert K; Goulet D; Gratton MO; Isakau H; Jang A; Khadir A; Koch E; Lavoie M; Lawless M; Nguyen M; Paquette D; Turcotte E; Berger A; Mitchell M; Shore GC; Beauparlant P
Mol Cell Biol; 2009 Nov; 29(21):5872-88. PubMed ID: 19703994
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.
Piacente F; Caffa I; Ravera S; Sociali G; Passalacqua M; Vellone VG; Becherini P; Reverberi D; Monacelli F; Ballestrero A; Odetti P; Cagnetta A; Cea M; Nahimana A; Duchosal M; Bruzzone S; Nencioni A
Cancer Res; 2017 Jul; 77(14):3857-3869. PubMed ID: 28507103
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD
Guo J; Lam LT; Longenecker KL; Bui MH; Idler KB; Glaser KB; Wilsbacher JL; Tse C; Pappano WN; Huang TH
Biochem Biophys Res Commun; 2017 Sep; 491(3):681-686. PubMed ID: 28756225
[TBL] [Abstract][Full Text] [Related]
10. Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models.
O'Brien T; Oeh J; Xiao Y; Liang X; Vanderbilt A; Qin A; Yang L; Lee LB; Ly J; Cosino E; LaCap JA; Ogasawara A; Williams S; Nannini M; Liederer BM; Jackson P; Dragovich PS; Sampath D
Neoplasia; 2013 Dec; 15(12):1314-29. PubMed ID: 24403854
[TBL] [Abstract][Full Text] [Related]
11. NAMPT is the cellular target of STF-31-like small-molecule probes.
Adams DJ; Ito D; Rees MG; Seashore-Ludlow B; Puyang X; Ramos AH; Cheah JH; Clemons PA; Warmuth M; Zhu P; Shamji AF; Schreiber SL
ACS Chem Biol; 2014 Oct; 9(10):2247-54. PubMed ID: 25058389
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of GLUTs by WZB117 mediates apoptosis in blood-stage Plasmodium parasites by breaking redox balance.
Wei M; Lu L; Sui W; Liu Y; Shi X; Lv L
Biochem Biophys Res Commun; 2018 Sep; 503(2):1154-1159. PubMed ID: 29953861
[TBL] [Abstract][Full Text] [Related]
13. NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for Chondrosarcoma.
Peterse EFP; van den Akker BEWM; Niessen B; Oosting J; Suijker J; de Jong Y; Danen EHJ; Cleton-Jansen AM; Bovée JVMG
Mol Cancer Res; 2017 Dec; 15(12):1714-1721. PubMed ID: 28860121
[TBL] [Abstract][Full Text] [Related]
14. Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).
Zheng X; Bair KW; Bauer P; Baumeister T; Bowman KK; Buckmelter AJ; Caligiuri M; Clodfelter KH; Feng Y; Han B; Ho YC; Kley N; Li H; Liang X; Liederer BM; Lin J; Ly J; O'Brien T; Oeh J; Oh A; Reynolds DJ; Sampath D; Sharma G; Skelton N; Smith CC; Tremayne J; Wang L; Wang W; Wang Z; Wu H; Wu J; Xiao Y; Yang G; Yuen PW; Zak M; Dragovich PS
Bioorg Med Chem Lett; 2013 Oct; 23(20):5488-97. PubMed ID: 24021463
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of an NAD⁺ salvage pathway provides efficient and selective toxicity to human pluripotent stem cells.
Kropp EM; Oleson BJ; Broniowska KA; Bhattacharya S; Chadwick AC; Diers AR; Hu Q; Sahoo D; Hogg N; Boheler KR; Corbett JA; Gundry RL
Stem Cells Transl Med; 2015 May; 4(5):483-93. PubMed ID: 25834119
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of GLUT/SLC2A Enhance the Action of BCNU and Temozolomide against High-Grade Gliomas.
Azzalin A; Nato G; Parmigiani E; Garello F; Buffo A; Magrassi L
Neoplasia; 2017 Apr; 19(4):364-373. PubMed ID: 28319810
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas.
Olesen UH; Hastrup N; Sehested M
APMIS; 2011 Apr; 119(4-5):296-303. PubMed ID: 21492230
[TBL] [Abstract][Full Text] [Related]
18. A Versatile Continuous Fluorometric Enzymatic Assay for Targeting Nicotinate Phosphoribosyltransferase.
Minazzato G; Marangoni E; Fortunato C; Petrelli R; Cappellacci L; Del Bello F; Sorci L; Gasparrini M; Piacente F; Bruzzone S; Raffaelli N
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770640
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner.
Cerna D; Li H; Flaherty S; Takebe N; Coleman CN; Yoo SS
J Biol Chem; 2012 Jun; 287(26):22408-17. PubMed ID: 22570471
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of transport and phosphorylation of glucose in cancer cells.
Rodríguez-Enríquez S; Marín-Hernández A; Gallardo-Pérez JC; Moreno-Sánchez R
J Cell Physiol; 2009 Dec; 221(3):552-9. PubMed ID: 19681047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
